This inventor holds 4 USPTO granted patents and 5 published patent applications, plus 8 CIPO patents and 2 EPO patents. Top assignees: University of Alberta, Wisconsin Alumni Research Foundation. Active years: 2005-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 455 
1 out of 4,238 
Years Active: 2005-2022
Title: Afsaneh Lavasanifar: Innovator in Biocompatible Polymers
Introduction
Afsaneh Lavasanifar is a prominent inventor based in Edmonton, Canada. She has made significant contributions to the field of biocompatible polymers, holding a total of 4 patents. Her work focuses on developing innovative compounds and materials that have applications in various bioactive agent delivery systems.
Latest Patents
Among her latest patents is the invention of imidopiperidine compounds as inhibitors of human polynucleotide kinase phosphatase. This patent describes the potential of these compounds in therapeutic applications. Another notable patent involves poly(ethylene oxide)-block-poly(ester) block copolymers. This invention relates to micelle-forming copolymers that possess reactive groups on the polyester block, enhancing their suitability as carriers for bioactive agents such as DNA, RNA, proteins, and drugs.
Career Highlights
Afsaneh Lavasanifar has worked with esteemed institutions, including the University of Alberta and the Wisconsin Alumni Research Foundation. Her research has significantly advanced the understanding and application of biocompatible materials in medical and pharmaceutical fields.
Collaborations
Some of her notable collaborators include Abdullah Mahmud and Glen S Kwon. Their joint efforts have contributed to the development of innovative solutions in the realm of biocompatible polymers.
Conclusion
Afsaneh Lavasanifar's work exemplifies the intersection of innovation and practical application in the field of biocompatible materials. Her contributions continue to influence advancements in drug delivery systems and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile